Clinical Trial Update: Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating Panitumumab-IRDye800 for fluorescence-guided diagnosis in patients with malignant glioma undergoing surgery; recruitment i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Glioma

Drugs mentioned

• Panitumumab-IRDye800

Snippet

Sponsor: Stanford University | Conditions: Malignant Brain Neoplasm, Malignant Glioma | Phase 1, Phase 2 | Status: RECRUITING